Machine learning assessment of endoscopic severity in Ulcerative Colitis trials: Model evaluation against the 2+1 reference standard

被引:0
作者
Battioui, C. [1 ]
Brodskiy, P. [2 ]
Gottlieb, K. [1 ]
Haft-Javaherian, M. [2 ]
Eastman, W. [1 ]
Lehrer, J. [2 ]
Yu, E. [2 ]
Onken, D. [3 ]
Thomason, D. [4 ]
Colucci, D. [4 ]
Reinisch, W. [5 ]
Baxi, S. [4 ]
机构
[1] Eli Lilly & Co, Clin Res, Indianapolis, IN USA
[2] Iterat Hlth Inc, Machine Learning, Cambridge, MA USA
[3] Eli Lilly & Co, Data Sci, Indianapolis, IN USA
[4] Iterat Hlth Inc, Data & Insights, Cambridge, MA USA
[5] Med Univ Vienna, Gastroenterol & Hepatol, Vienna, Austria
关键词
D O I
10.1093/ecco-jcc/jjae190.0117
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP078
引用
收藏
页码:i227 / i228
页数:2
相关论文
共 4 条
  • [1] Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials
    Feagan, Brian G.
    Khanna, Reena
    Sandborn, William J.
    Vermeire, Severine
    Reinisch, Walter
    Su, Chinyu
    Salese, Leonardo
    Fan, Haiyun
    Paulissen, Jerome
    Woodworth, Deborah A.
    Niezychowski, Wojciech
    Sands, Bruce E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1442 - 1453
  • [2] Food and Drug Administration, 2022, Ulcerative Colitis: Developing Drugs for Treatment Internet
  • [3] Hashash J. G., 2024, Inflammatory Bowel Diseases
  • [4] Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease
    Wils, Pauline
    Jairath, Vipul
    Sands, Bruce E.
    Magro, Fernando
    Reinisch, Walter
    Rubin, David
    Danese, Silvio
    Baumann, Cedric
    Peyrin-Biroulet, Laurent
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (08) : 797 - 806